PMID: 6980592Jan 1, 1981Paper

Evaluation of the neurophysiologic effects of 1,2-propylene glycol dinitrate by quantitative ataxia and oculomotor function tests

American Journal of Industrial Medicine
E P HorvathT Markham

Abstract

1,2-Propylene glycol dinitrate (PGDN), a nitrated ester found in the torpedo propellant Otto Fuel II, has been suspected of causing neurologic and cardiovascular effects. This study evaluated the possible acute and chronic neurophysiologic toxicity of PGDN in U.S. Navy torpedo facilities. The test procedures included a medical and occupational history, neuro-ophthalmologic examination, and quantitative tests of both oculomotor function and ataxia. A study population of 87 workers chronically exposed (CE) to PGDN during torpedo maintenance procedures was compared to a group of 21 controls (CON). Although workers often complained of vascular effects (headaches, nasal congestion), no evidence of chronic neurotoxicity was found, even among a subgroup of workers (CEsub) with the longest total duration of exposure. To detect possible acute effects, 29 subjects from the study group were tested before and immediately after PGDN exposure during a torpedo maintenance procedure or turnaround (TA). These personnel had a statistically significant decline in saccade velocity and a prolongation of saccade delay time, even though most peak airborne concentrations of PGDN were well below 0.2 ppm.

References

Jan 1, 1979·Scientific American·A T Bahill, L Stark
Nov 1, 1975·Neurology·R W BalohV Honrubia
Dec 1, 1974·Brain : a Journal of Neurology·I M WilkinsonM Purnell
Dec 1, 1974·Toxicology and Applied Pharmacology·R D StewartG M Lawton
May 1, 1972·Toxicology and Applied Pharmacology·R A JonesJ Siegel
Aug 1, 1974·Archives of General Psychiatry·P S HolzmanS W Hurt
Jan 1, 1970·Archiv für Psychiatrie und Nervenkrankheiten·M C Franck, W Kuhlo
Jul 1, 1971·Clinical Pharmacology and Therapeutics·W Gentles, E L Thomas
Jul 1, 1969·Toxicology and Applied Pharmacology·D G Clark, M H Litchfield
Nov 1, 1954·A.M.A. Archives of Ophthalmology·G WESTHEIMER
Oct 1, 1963·Archives of Environmental Health·P CARMICHAEL, J LIEBEN
Sep 1, 1963·American Industrial Hygiene Association Journal·C EINERTF OTTOBONI

❮ Previous
Next ❯

Citations

Jul 1, 1986·Archives of Environmental Health·K D RosenmanA Cinotti
Jan 1, 1987·Journal of Toxicology and Environmental Health·V BogoJ Nold
Jul 1, 1993·Journal of Applied Toxicology : JAT·J R CooperD A Macys
Mar 19, 2005·American Journal of Industrial Medicine·John S Morawetz
Jan 1, 1988·Acta Oto-laryngologica. Supplementum·B I Wenngren, L M Odkvist
Jul 1, 1991·The Journal of Laryngology and Otology·J C TonerA G Kerr
Jan 1, 1989·The Journal of Laryngology and Otology·N B Solomons, J M Robinson
Jan 1, 1984·International Archives of Occupational and Environmental Health·L GlickmanI Weisman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Ataxias

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on different types of ataxias here.

Ataxias (MDS)

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.

Ataxia

Ataxia is a neurological condition characterized by lack of voluntary coordination of muscle movements including loss of coordination, balance, and speech. Discover the latest research on ataxia here.